Orano Med
Remi Marcoux has been serving as a Technicien soutien Projet et Maintenance at Orano Med since September 2018, following a role as alternant technicien instrumentation et projet. Prior to this, Remi gained experience at AVIA France from July 2012 to August 2018 as an Employé étudiant, where responsibilities included seasonal work in a service station, encompassing roles in restauration, maintenance of green spaces, automotive mechanics, and customer service. Educational qualifications include a Licence professionnelle in Capteurs, Instrumentation, Mesures et Essais from IUT Mesures Physiques Limoges (2018-2019), a Brevet de Technicien Supérieur in Contrôles Industriels et Régulation Automatique from Université de Limoges (2016-2018), a DUT in Chimie from Université de Poitiers (2012-2015), and a Baccalauréat in Sciences de l'ingénieur from lycée Paul Turgot (2009-2012).
This person is not in any offices
Orano Med
1 followers
Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information please visit www.macrocyclics.com.